Beacon Biosignals Integrates CleveMed, SleepView Under Unified Brand
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The FDA authorizes Beacon Biosignals' Predetermined Change Control Plan for the Dreem 3S EEG headband, enabling continuous algorithm updates to advance sleep monitoring and clinical-grade EEG analytics.
Newly discovered sleep biomarkers pave the way for early detection of Parkinson’s disease, Alzheimer’s disease, Lewy body dementia, and other neurodegenerative diseases. They may also one day lead to interventions.
Read More